These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 34711217)
21. Effects of matrine on JAK-STAT signaling transduction pathways in bleomycin-induced pulmonary fibrosis. Ma X; Chen R; Liu X; Xie J; Si K; Duan L Afr J Tradit Complement Altern Med; 2013; 10(3):442-8. PubMed ID: 24146473 [TBL] [Abstract][Full Text] [Related]
22. IL-35 Suppresses Lipopolysaccharide-Induced Airway Eosinophilia in EBI3-Deficient Mice. Kanai K; Park AM; Yoshida H; Tsunoda I; Yoshie O J Immunol; 2017 Jan; 198(1):119-127. PubMed ID: 27881708 [TBL] [Abstract][Full Text] [Related]
23. Deficiency of CARMA3 attenuates the development of bleomycin induced pulmonary fibrosis. Wu Y; Qi Y; Qiu Z; Chen W Biochem Biophys Res Commun; 2021 Dec; 581():81-88. PubMed ID: 34656852 [TBL] [Abstract][Full Text] [Related]
24. Cryptotanshinone protects against pulmonary fibrosis through inhibiting Smad and STAT3 signaling pathways. Zhang Y; Lu W; Zhang X; Lu J; Xu S; Chen S; Zhong Z; Zhou T; Wang Q; Chen J; Liu P Pharmacol Res; 2019 Sep; 147():104307. PubMed ID: 31181334 [TBL] [Abstract][Full Text] [Related]
25. Genetic ablation of caveolin-2 sensitizes mice to bleomycin-induced injury. de Almeida CJ; Jasmin JF; Del Galdo F; Lisanti MP Cell Cycle; 2013 Jul; 12(14):2248-54. PubMed ID: 24067367 [TBL] [Abstract][Full Text] [Related]
26. Cthrc1 lowers pulmonary collagen associated with bleomycin-induced fibrosis and protects lung function. Binks AP; Beyer M; Miller R; LeClair RJ Physiol Rep; 2017 Mar; 5(5):. PubMed ID: 28292882 [TBL] [Abstract][Full Text] [Related]
27. Honokiol: A polyphenol neolignan ameliorates pulmonary fibrosis by inhibiting TGF-β/Smad signaling, matrix proteins and IL-6/CD44/STAT3 axis both in vitro and in vivo. Pulivendala G; Bale S; Godugu C Toxicol Appl Pharmacol; 2020 Mar; 391():114913. PubMed ID: 32032644 [TBL] [Abstract][Full Text] [Related]
28. Thalidomide prevents bleomycin-induced pulmonary fibrosis in mice. Tabata C; Tabata R; Kadokawa Y; Hisamori S; Takahashi M; Mishima M; Nakano T; Kubo H J Immunol; 2007 Jul; 179(1):708-14. PubMed ID: 17579094 [TBL] [Abstract][Full Text] [Related]
29. Interleukin (IL)-39 [IL-23p19/Epstein-Barr virus-induced 3 (Ebi3)] induces differentiation/expansion of neutrophils in lupus-prone mice. Wang X; Liu X; Zhang Y; Wang Z; Zhu G; Han G; Chen G; Hou C; Wang T; Ma N; Shen B; Li Y; Xiao H; Wang R Clin Exp Immunol; 2016 Nov; 186(2):144-156. PubMed ID: 27400195 [TBL] [Abstract][Full Text] [Related]
30. Asporin Promotes TGF-β-induced Lung Myofibroblast Differentiation by Facilitating Rab11-Dependent Recycling of TβRI. Huang S; Lai X; Yang L; Ye F; Huang C; Qiu Y; Lin S; Pu L; Wang Z; Huang W Am J Respir Cell Mol Biol; 2022 Feb; 66(2):158-170. PubMed ID: 34705621 [TBL] [Abstract][Full Text] [Related]
32. The role of the receptor for advanced glycation end-products in lung fibrosis. He M; Kubo H; Ishizawa K; Hegab AE; Yamamoto Y; Yamamoto H; Yamaya M Am J Physiol Lung Cell Mol Physiol; 2007 Dec; 293(6):L1427-36. PubMed ID: 17951314 [TBL] [Abstract][Full Text] [Related]
33. Th17 cells and IL-17 promote the skin and lung inflammation and fibrosis process in a bleomycin-induced murine model of systemic sclerosis. Lei L; Zhao C; Qin F; He ZY; Wang X; Zhong XN Clin Exp Rheumatol; 2016; 34 Suppl 100(5):14-22. PubMed ID: 26750756 [TBL] [Abstract][Full Text] [Related]
34. IL20Rb aggravates pulmonary fibrosis through enhancing bone marrow derived profibrotic macrophage activation. Zhu J; Jiang Q; Gao S; Xia Q; Zhang H; Liu B; Zhao R; Jiang H; Li X; Xu A; Zhou H; Xu Z; Yang C Pharmacol Res; 2024 May; 203():107178. PubMed ID: 38583686 [TBL] [Abstract][Full Text] [Related]
35. Fluorofenidone attenuates pulmonary inflammation and fibrosis via inhibiting the activation of NALP3 inflammasome and IL-1β/IL-1R1/MyD88/NF-κB pathway. Song C; He L; Zhang J; Ma H; Yuan X; Hu G; Tao L; Zhang J; Meng J J Cell Mol Med; 2016 Nov; 20(11):2064-2077. PubMed ID: 27306439 [TBL] [Abstract][Full Text] [Related]
36. Tauroursodeoxycholic acid alleviates pulmonary endoplasmic reticulum stress and epithelial-mesenchymal transition in bleomycin-induced lung fibrosis. Tong B; Fu L; Hu B; Zhang ZC; Tan ZX; Li SR; Chen YH; Zhang C; Wang H; Xu DX; Zhao H BMC Pulm Med; 2021 May; 21(1):149. PubMed ID: 33952237 [TBL] [Abstract][Full Text] [Related]
37. Lack of evidence for expression and function of IL-39 in human immune cells. Ecoeur F; Weiss J; Schleeger S; Guntermann C PLoS One; 2020; 15(12):e0242329. PubMed ID: 33259477 [TBL] [Abstract][Full Text] [Related]
39. Inhibition of ROCK ameliorates pulmonary fibrosis by suppressing M2 macrophage polarisation through phosphorylation of STAT3. Li Q; Cheng Y; Zhang Z; Bi Z; Ma X; Wei Y; Wei X Clin Transl Med; 2022 Oct; 12(10):e1036. PubMed ID: 36178087 [TBL] [Abstract][Full Text] [Related]
40. Effects of montelukast, a cysteinyl-leukotriene type 1 receptor antagonist, on the pathogenesis of bleomycin-induced pulmonary fibrosis in mice. Shimbori C; Shiota N; Okunishi H Eur J Pharmacol; 2011 Jan; 650(1):424-30. PubMed ID: 21034736 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]